The multiple mechanisms of MCL1 in the regulation of cell fate

H Widden, WJ Placzek - Communications Biology, 2021 - nature.com
Abstract MCL1 (myeloid cell leukemia-1) is a widely recognized pro-survival member of the
Bcl-2 (B-cell lymphoma protein 2) family and a promising target for cancer therapy. While the …

Targeting MCL-1 protein to treat cancer: opportunities and challenges

SI Tantawy, N Timofeeva, A Sarkar, V Gandhi - Frontiers in oncology, 2023 - frontiersin.org
Evading apoptosis has been linked to tumor development and chemoresistance. One
mechanism for this evasion is the overexpression of prosurvival B-cell lymphoma-2 (BCL-2) …

Understanding MCL1: from cellular function and regulation to pharmacological inhibition

M Sancho, D Leiva, E Lucendo, M Orzáez - The FEBS Journal, 2022 - Wiley Online Library
Myeloid cell leukemia‐1 (MCL1), an antiapoptotic member of the BCL2 family characterized
by a short half‐life, functions as a rapid sensor that regulates cell death and other relevant …

Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions

H Deng, Y Han, L Liu, H Zhang, D Liu… - Journal of Medicinal …, 2024 - ACS Publications
As a tripartite cell death switch, B-cell lymphoma protein 2 (Bcl-2) family members precisely
regulate the endogenous apoptosis pathway in response to various cell signal stresses …

MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma

D Fu, L Pfannenstiel, A Demelash, YP Phoon… - Cell Death & …, 2022 - nature.com
Colorectal cancer (CRC) is one of the most common and deadliest forms of cancer. Myeloid
Cell Leukemia 1 (MCL1), a pro-survival member of the Bcl-2 protein family is associated with …

Polypyrimidine tract binding protein 1 (PTBP1) contains a novel regulatory sequence, the rBH3, that binds the prosurvival protein MCL1

C Carico, J Cui, A Acton, WJ Placzek - Journal of Biological Chemistry, 2023 - ASBMB
The maturation of RNA from its nascent transcription to ultimate utilization (eg, translation,
miR-mediated RNA silencing, etc.) involves an intricately coordinated series of biochemical …

Phylogenetic analysis of the MCL1 BH3 binding groove and rBH3 sequence motifs in the p53 and INK4 protein families

A McGriff, WJ Placzek - Plos one, 2023 - journals.plos.org
B-cell lymphoma 2 (Bcl-2) proteins are central, conserved regulators of apoptosis. Bcl-2
family function is regulated by binding interactions between the Bcl-2 homology 3 (BH3) …

Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: A single arm, prospective, phase II study

H Zhou, Q Liu, D Zhang, Q Li, D Cao, N Cheng… - International Journal of …, 2024 - Elsevier
Objective Non-platinum chemotherapy is used in platinum resistant/refractory ovarian
cancer patients but offers limited efficacy, especially in those who develop platinum …

Thymoquinone alterations of the apoptotic gene expressions and cell cycle arrest in genetically distinct triple-negative breast cancer cells

GM Adinew, SS Messeha, E Taka, RB Badisa… - Nutrients, 2022 - mdpi.com
Breast cancer (BC) is the most common cancer in women worldwide, and it is one of the
leading causes of cancer death in women. triple-negative breast Cancer (TNBC), a subtype …

Myeloid Cell Leukemia 1 Small Molecule Inhibitor S63845 Synergizes with Cisplatin in Triple-Negative Breast Cancer

A Acton, WJ Placzek - Cancers, 2023 - mdpi.com
Simple Summary This manuscript builds on our recent observations that the cell-death-
suppressing protein, MCL1, is able to directly regulate the DNA damage response …